During pregnancy, some of the fetal DNA crosses the placenta and enters the mother's bloodstream. NIPT involves drawing a blood sample from the mother and analyzing this cell-free fetal DNA (cffDNA). The test can detect chromosomal abnormalities by examining the quantity and structure of the fetal DNA.
